Teleflex Innovation S.A.R.L. (Teleflex) owns multiple patents to a dual catheter design, wherein an extension catheter is disposed within a larger guide catheter coaxially. This coaxial orientation ...

Teleflex is launching new products, acquiring Biotronik’s vascular unit, and splitting into two companies to reignite growth and unlock value. Margins are strong, the balance sheet is solid, and cash ...

Teleflex Incorporated has successfully completed its acquisition of the Vascular Intervention business from BIOTRONIK SE & Co. KG for €760 million. This acquisition enhances Teleflex’s portfolio in ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Teleflex plans to spin off its Urology, Acute Care, and OEM businesses into a new public company by mid-2026. Teleflex Incorporated announced its plan to separate its Urology, Acute Care, and OEM ...

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced its financial results for the first quarter of 2025, delivering revenue and earnings that aligned with expectations. While the company faced ...

Teleflex today announced that its Arrow FlexTip Plus Closed Tip epidural catheter has received clearance from the U.S. Food and Drug Administration. The closed tip, multi-port catheter provides kink ...

Teleflex has a leading market position in CVCs, and though this does not guarantee future returns, we contend that Teleflex’s portfolio of antimicrobial catheters will ensure the continuation of ...

Teleflex (TFX) has quietly become a talking point after another choppy week for medtech names, with the stock drifting lower over the past week even as the past month’s performance turned positive.